You searched for "ENT surgery"

215 results found

Should we routinely perform steroid injections following microlaryngeal excision of benign lesions?

This retrospective cohort study assessed a single surgeon’s outcomes before and after the routine administration of intralesional triamcinolone following microsurgical removal of benign vocal fold lesions (polyps, nodules and cysts). A total of 211 patients were recruited for the study....

What is the optimum duration of voice rest after microlaryngoscopy procedures?

Recent survey data looking at the opinions and practices of otolaryngologists in the US and the UK demonstrate that there is a wide variation in recommendations made for voice rest after vocal fold surgery. In the US, the most common...

Voice outcomes following extended laser resections for laryngeal cancer

It is now widely accepted that the oncological and voice outcomes following transoral laser microsurgery for early T1a glottic cancers are equivalent to, if not superior to, traditional radiotherapy. Voice outcomes following more extensive resections have not been as frequently...

Dysplasia at the margins of laryngeal cancer specimens following laser resection – is conservative management appropriate?

Transoral laser microsurgery (TOLM) remains the cornerstone of treatment for early laryngeal squamous cell carcinomas. Whilst the hope is always to achieve a complete surgical excision with clear margins, it is sometimes the case that on histological analysis, disease is...

Transoral coblation surgery – a viable option for early laryngeal cancers involving the anterior commissure?

Transoral laser microsurgery is widely considered to represent the ideal treatment modality for early (T1a) laryngeal cancers. With disease involving the anterior commissure however, radiotherapy is often advocated on account of perceived superior voice and airway outcomes, plus potential difficulty...

TRIBUTE: Ugo Fisch

EAONO collected in tributes from colleagues of Ugo Fisch who passed away on 12th December 2019 at the age of 88.  

In conversation with Professor N Isshiki: History of laryngeal framework

Mr Yakubu Karagama recently returned from a travelling fellowship at Isshiki Memorial Clinic Kyoto where he was delighted to interview Professor Isshiki about his groundbreaking work in laryngeal framework surgery. Professor Isshiki (left) discusses the history of thyroplasty with Mr...

Centenary birthday of Jean-Marc Sterkers: pioneer of vestibular schwannoma surgery

Professor Jean-Marc Sterkers has been a leading figure in the field of otology and neurotology for several decades. On the verge of his 100th birthday, we celebrate an exceptional career through the memories of his son and colleagues. Prof Olivier...

COVID-19 in China: the experience of an ENT team

In January, we first heard of COVID-19. As we currently do battle with it on our own shores, colleagues in China share their story with us as life there slowly and cautiously begins to return to normal and the country...

Complications in Otolaryngology – Head and Neck Surgery, First Edition

This is a volume compiled into a ‘handy reading’ format on Complications in Otolaryngology – Head and Neck Surgery, which cites as its special features: 1) the first complete, one-volume source on risks and complications in otology, rhinology, and head...

Intraoperative identification of primary tumours in unknown primary head and neck cancer using transoral laser microsurgery with frozen sections

The aim of the study was to compare the sensitivity and specificity of intraoperative identification of primary tumours in patients with unknown primary head and neck squamous cell carcinoma (UP HNSCC) using transoral laser microsurgery (TLM) with frozen sections, with...

Outcomes of larger glottic cancer volumes treated with radiotherapy

T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...